ABSTRACT
Dendrimers as drug carriers can be utilized for drugs and siRNA delivery in central nervous system (CNS) disorders, including various types of cancers, such as neuroblastomas and gliomas. They have also been considered as drugs per se, for example as anti-Alzheimer's disease (AD), anti-cancer, anti-prion or anti-inflammatory agents. Since the influence of carbosilane-viologen-phosphorus dendrimers (SMT1 and SMT2) on the basic cellular processes of nerve cells had not been investigated, we examined the impact of two generations of these hybrid macromolecules on two murine cell lines-cancer cell line N2a (mouse neuroblastoma) and normal immortalized cell line mHippoE-18 (embryonic mouse hippocampal cell line). We examined alterations in cellular responses including the activity of mitochondrial dehydrogenases, the generation of reactive oxygen species (ROS), changes in mitochondrial membrane potential, and morphological modifications and fractions of apoptotic and dead cells. Our results show that both dendrimers at low concentrations affected the cancer cell line more than the normal one. Also, generation-dependent effects were found: the highest generation induced greater cytotoxic effects and morphological modifications. The most promising is that the changes in mitochondrial membrane potential and transmission electron microscopy (TEM) images indicate that dendrimer SMT1 can reach mitochondria. Thus, SMT1 and SMT2 seem to have potential as nanocarriers to mitochondria or anti-cancer drugs per se in CNS disorders.
Subject(s)
Dendrimers/pharmacology , Membrane Potentials/drug effects , Mitochondria , Neuroblastoma , Neurons , Reactive Oxygen Species/metabolism , Animals , Cell Line, Tumor , Dendrimers/chemistry , Mice , Mitochondria/metabolism , Mitochondria/ultrastructure , Neuroblastoma/drug therapy , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , Neurons/metabolism , Neurons/ultrastructureABSTRACT
Neuroblastoma is an aggressive form of cancer with high mortality. Hydroxychalcones have received considerable attention because of their cytotoxic activities on cancer cells. However, the effect of the 4'-hydroxychalcone on neuroblastoma cells is unknown. The aim of the present study was to characterize the cytotoxicity of 4HC to neuroblastoma and the importance of mitochondrial effects in its action mechanism using an in vitro model of SH-SY5Y cells. Incubation of cultured SHSY5Y cells with 10-60⯵M 4HC (24â¯h) decreased cell confluency, cellular metabolic activity and depleted intracellular ATP relative to the vehicle-treated control. The mechanism of 4HC-induced cell toxicity likely involves mitochondria dysfunctional as judged by inhibition of mitochondrial respiration, depolarization of mitochondria membrane potential and intracellular and morphological alterations. Furthermore, loss of cell viability was accompanied mainly by increase of phosphatidylserine exposure on the surface of cells, suggesting that the flavonoid may induce apoptosis in SH-SY5Y cells. In addition, treatment inhibited SH-SY5Y cell migration/proliferation in a scratch assay and induced significant changes in the cell cycle progression. Our results showed the effects of 4HC in the human neuroblastoma cell line SH-SY5Y are associated with mitochondrial dysfunctional, depletion of intracellular ATP levels, ROS increase, alteration in cell cycle progression and cellular morphology.
Subject(s)
Antineoplastic Agents/pharmacology , Chalcones/pharmacology , Neuroblastoma/drug therapy , Adenosine Triphosphate/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , Reactive Oxygen Species/metabolismABSTRACT
BACKGROUND: The activity of MP1, a pyrrolomycin, was studied in MYCN amplified neuroblastoma (NB) alone and combined with temsirolimus (TEM). METHODS: Activity of MP1 was tested in MYCN amplified (BE-2c, IMR) and non amplified (SKN-AS) NB cells. The effect of MP1 on MYCN, MCL-1, cleaved PARP, LC3II/LC3I, bcl-2, BAX, and BRD-4 were determined by western blot and RNAseq. The effect of MP1 on metabolism, mitochondrial morphology, and cell cycle was determined. Toxicology and efficacy of MP1 plus TEM were evaluated. RESULTS: The IC50 of MP1 was 0.096 µM in BE-2c cells compared to 0.89 µM in IMR, and >50 µM in SKN-AS. The IC50 of MP1 plus TEM in BE-2c cells was 0.023 µM. MP1 inhibited metabolism leading to quiescence and produced a decline in cell cycle S-phase. Electron microscopy showed cristae loss and rounding up of mitochondria. Gene and protein expression for MYCN and MCL-1 declined while LCII and cleaved PARP increased. Protein expression of BAX, bcl-2, and BRD-4 were not significantly changed after MP1 treatment. The in-vivo concentrations of MP1 in blood and tumor were sufficient to produce the biologic effects seen in-vitro. MP1 plus TEM produced a complete response in 3 out of 5 tumor bearing mice. In a second mouse study, the combination of MP1 and TEM slowed tumor growth compared to control. CONCLUSIONS: MP1 has a potent inhibitory effect on the viability of MYCN amplified NB. Inhibition of metabolism by MP1 induced quiescence and autophagy with a favorable toxicology and drug distribution profile. When combined with TEM anti-tumor activity was potentiated in-vitro and in-vivo.
Subject(s)
Antineoplastic Agents/pharmacology , Drug Resistance, Neoplasm/drug effects , Drug Resistance, Neoplasm/genetics , Gene Amplification , N-Myc Proto-Oncogene Protein/genetics , Pyrroles/pharmacology , Sirolimus/analogs & derivatives , Animals , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Biomarkers , Cell Cycle/drug effects , Cell Line, Tumor , Disease Models, Animal , Drug Interactions , Humans , Mice , Molecular Structure , Neuroblastoma/genetics , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , Pyrroles/chemistry , Sirolimus/chemistry , Sirolimus/pharmacology , Spectrum Analysis , Xenograft Model Antitumor AssaysABSTRACT
It has been reported that the main function of tau protein is to stabilize microtubules and promote the movement of organelles through the axon in neurons. In Alzheimer's disease, tau protein is the major constituent of the paired helical filament, and it undergoes post-translational modifications including hyperphosphorylation and truncation. Whether other functions of tau protein are involved in Alzheimer's disease is less clear. We used SH-SY5Y human neuroblastoma cells as an in vitro model to further study the functions of tau protein. We detected phosphorylated tau protein as small dense dots in the cell nucleus, which strongly colocalize with intranuclear speckle structures that were also labelled with an antibody to SC35, a protein involved in nuclear RNA splicing. We have shown further that tau protein, phosphorylated at the sites recognized by pT231, TG-3, and AD2 antibodies, is closely associated with cell division. Different functions may be characteristic of phosphorylation at specific sites. Our findings suggest that the presence of tau protein is involved in separation of sister chromatids in anaphase, and that tau protein also participates in maintaining the integrity of the DNA (pT231, prophase) and chromosomes during cell division (TG-3).
Subject(s)
Cell Cycle/physiology , Gene Expression Regulation, Neoplastic , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , tau Proteins/biosynthesis , Aged , Aged, 80 and over , Cell Line, Tumor , Female , Humans , Male , Middle Aged , Neuroblastoma/genetics , Phosphorylation/physiology , tau Proteins/geneticsABSTRACT
Olfactory neuroblastoma (ONB) is a rare intranasal neoplasm in both dogs and humans. Similar clinical presentation and overlapping histologic and immunohistochemical features of ONB with other intranasal neoplasms can make diagnosis and treatment of intranasal neoplasia challenging. Furthermore, in part because of their rarity, there is a lack of reporting on therapeutic regimen for these neoplasms. In humans, initial debulking surgery is usually followed by radiation therapy. Here we report on the histologic, immunohistochemical, and ultrastructural characteristics of canine ONB and report on the clinical progression of cases treated with radiation therapy. In all nine canine ONB examined here, neoplastic cells were arranged in a lobular manner amidst a prominent neurofibrillary matrix and had features consistent with Grade III (high grade) ONB. The neoplastic cells demonstrated positive immunohistochemical staining for TuJ-1, a Class III beta-tubulin neuronal cytoskeletal protein, and variable staining for other markers, including chromogranin, synaptophysin, AE1/AE3 and MAP2. The longest surviving case was treated with a regimen similar to that used in humans, consisting of debulking surgery followed by definitive radiation therapy. Our study found that TuJ-1 is a useful marker for ONB and that radiation therapy, even in cases of advanced disease, may result in prolonged survival.
Subject(s)
Dog Diseases/therapy , Neuroblastoma/veterinary , Nose Neoplasms/veterinary , Animals , Dog Diseases/pathology , Dogs , Female , Male , Neuroblastoma/pathology , Neuroblastoma/therapy , Neuroblastoma/ultrastructure , Nose Neoplasms/pathology , Nose Neoplasms/therapyABSTRACT
Consumption of bufadienolide-containing plants are responsible for many livestock mortalities annually. Bufadienolides are divided into two groups; non-cumulative bufadienolides and cumulative bufadienolides. Cumulative bufadienolides are referred to as neurotoxic, as the chronic intoxication with this type of bufadienolide results in a paretic/paralytic syndrome known as 'krimpsiekte'. The in vitro cytotoxicity of a non-cumulative bufadienolide, 1α,2α-epoxyscillirosidine, and a cumulative bufadienolide, lanceotoxin B, were compared using the MTT ((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction) assay after exposing rat myocardial (H9c2) and mouse neuroblastoma (Neuro-2a) cell lines. The effect of these two bufadienolides on cell ultrastructure was also investigated using transmission electron microscopy (TEM). H9c2 cells exhibited greater cytotoxicity when exposed to 1α,2α-epoxyscillirosidine, compared to lanceotoxin B. In contrast, Neuro-2a cells were more susceptible to lanceotoxin B. The EC50 (half maximal effective concentration) of lanceotoxin B exposure of Neuro-2a cells for 24â»72 h ranged from 4.4â»5.5 µM compared to EC50s of 35.7â»37.6 µM for 1α,2α-epoxyscillirosidine exposure of Neuro-2a cells over the same period. 1α,2α-Epoxyscillirosidine induced extensive vacuolization in both cell types, with swollen RER (rough endoplasmic reticulum) and perinuclear spaces. Lanceotoxin B caused swelling of the mitochondria and sequestration of cytoplasmic material within autophagic vesicles. These results corroborate the notion that cumulative bufadienolides are neurotoxic.
Subject(s)
Bufanolides/toxicity , Neurotoxins/toxicity , Animals , Cell Line , Cell Survival/drug effects , Mice , Myocardium/cytology , Neuroblastoma/ultrastructure , RatsABSTRACT
Cisplatin (cisPt), among the best known components of multi-drug front-line therapies used for the treatments of solid tumors, such as the childhood neuroblastoma, acts through DNA linking. Nevertheless, the cisPt effectiveness is compromised by the onset of severe side effects, including neurotoxicity that results in neurodegeneration, cell death, and drug-resistance. In the field of experimental oncology, aimed at overcoming cytotoxicity and chemoresistance, great efforts are devoted to the synthesis of new platinum-based drugs, such as [Pt(O,O'-acac)(γ-acac)(DMS)] (PtAcacDMS), which shows a specific reactivity with sulfur residues of enzymes involved in apoptosis. Autophagy, an evolutionary conserved degradation pathway for recycling of cytoplasmic components, represents one of the mechanisms adopted by cancer cells which contribute to drug-resistance. In the present study, standard acute (48â¯h-exposure) and long-term effects (7â¯day-recovery after treatment or 7â¯day-recovery followed by reseeding and 96â¯h-growth), of cisPt and PtAcacDMS (40 and 10⯵M, respectively) were investigated in vitro employing rat B50 neuroblastoma as a cancer model. Using fluorescence and electron microscopy, as well as biochemical techniques, our data highlight a key role of the autophagic process in B50 cells. Specifically, long-term effects caused by cisPt lead to inhibition of the apoptotic process and paralleled by the activation of autophagy, thus evidencing that autophagy has a protective role after cisPt exposure, allowing cells to survive. Whereas, long-term effects produced by PtAcacDMS lead toward both apoptosis and autophagy activation. In conclusion, autophagy may represents an alternative cell death pathway, circumventing drug-resistance strategies employed by cancer cells to survive chemoterapy.
Subject(s)
Antineoplastic Agents/pharmacology , Autophagy/drug effects , Cisplatin/pharmacology , Neuroblastoma/drug therapy , Organoplatinum Compounds/pharmacology , Animals , Antineoplastic Agents/toxicity , Apoptosis/drug effects , Autophagy-Related Protein 5/metabolism , Beclin-1/metabolism , Cell Line, Tumor , Cisplatin/toxicity , Drug Resistance, Neoplasm , Lysosomes/drug effects , Lysosomes/metabolism , Lysosomes/ultrastructure , Microtubule-Associated Proteins/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondria/ultrastructure , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , Rats , Sequestosome-1 Protein/metabolism , Signal Transduction/drug effects , Time FactorsABSTRACT
Tau is known for its pathological role in neurodegenerative diseases, including Alzheimer's disease (AD) and other tauopathies. Tau is found in many subcellular compartments such as the cytosol and the nucleus. Although its normal role in microtubule binding is well established, its nuclear role is still unclear. Here, we reveal that tau localises to the nucleolus in undifferentiated and differentiated neuroblastoma cells (SHSY5Y), where it associates with TIP5, a key player in heterochromatin stability and ribosomal DNA (rDNA) transcriptional repression. Immunogold labelling on human brain sample confirms the physiological relevance of this finding by showing tau within the nucleolus colocalises with TIP5. Depletion of tau results in an increase in rDNA transcription with an associated decrease in heterochromatin and DNA methylation, suggesting that under normal conditions tau is involved in silencing of the rDNA. Cellular stress induced by glutamate causes nucleolar stress associated with the redistribution of nucleolar non-phosphorylated tau, in a similar manner to fibrillarin, and nuclear upsurge of phosphorylated tau (Thr231) which doesn't colocalise with fibrillarin or nucleolar tau. This suggests that stress may impact on different nuclear tau species. In addition to involvement in rDNA transcription, nucleolar non-phosphorylated tau also undergoes stress-induced redistribution similar to many nucleolar proteins.
Subject(s)
Cell Nucleolus/drug effects , Cell Nucleolus/metabolism , Excitatory Amino Acid Agonists/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Glutamic Acid/pharmacology , tau Proteins/metabolism , Brain/metabolism , Brain/ultrastructure , Cell Differentiation/physiology , Cell Line, Tumor , Cell Nucleolus/ultrastructure , Chromosomal Proteins, Non-Histone/metabolism , Chromosomal Proteins, Non-Histone/ultrastructure , DNA, Ribosomal/genetics , DNA, Ribosomal/metabolism , Gene Expression Regulation, Neoplastic/genetics , Heterochromatin/physiology , Histones/metabolism , Humans , Immunoprecipitation , Microscopy, Confocal , Microscopy, Electron , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Protein Transport/drug effects , RNA, Messenger , RNA, Small Interfering/genetics , RNA, Small Interfering/metabolism , Transcription, Genetic/drug effects , Transfection , tau Proteins/genetics , tau Proteins/ultrastructureABSTRACT
Abnormal fibrillary aggregation of tau protein is a pathological condition observed in Alzheimer's disease and other tauopathies; however, the presence and pathological significance of early non-fibrillary aggregates of tau remain under investigation. In cell and animal models expressing normal or modified tau, toxic effects altering the structure and function of several membranous organelles have also been reported in the absence of fibrillary structures; however, how these abnormalities are produced is an issue yet to be addressed. In order to obtain more insights into the mechanisms by which tau may disturb intracellular membranous elements, we transiently overexpressed human full-length tau and several truncated tau variants in cultured neuroblastoma cells. After 48âh of transfection, either full-length or truncated tau forms produced significant fragmentation of the Golgi apparatus (GA) with no changes in cell viability. Noteworthy is that in the majority of cells exhibiting dispersion of the GA, a ring-shaped array of cortical or perinuclear microtubule (Mt) bundles was also generated under the expression of either variant of tau. In contrast, Taxol treatment of non-transfected cells increased the amount of Mt bundles but not sufficiently to produce fragmentation of the GA. Tau-induced ring-shaped Mt bundles appeared to be well-organized and stable structures because they were resistant to Nocodazole post-treatment and displayed a high level of tubulin acetylation. These results further indicate that a mechanical force generated by tau-induced Mt-bundling may be responsible for Golgi fragmentation and that the repeated domain region of tau may be the main promoter of this effect.
Subject(s)
Cytoskeleton/metabolism , Golgi Apparatus/metabolism , Golgi Apparatus/ultrastructure , Microtubules/metabolism , Neuroblastoma/ultrastructure , tau Proteins/metabolism , Brefeldin A/pharmacology , Carbohydrate Metabolism/physiology , Cell Line, Tumor , Cell Survival/physiology , Gene Expression Regulation, Neoplastic/genetics , Glycoproteins/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Mutation/genetics , Neuroblastoma/pathology , Nocodazole/pharmacology , Organic Chemicals/metabolism , Protein Synthesis Inhibitors/pharmacology , Transfection , tau Proteins/geneticsABSTRACT
α-Synuclein, a major constituent of proteinaceous inclusions named Lewy body, has been shown to be released and taken up by cells, which may facilitate its progressive pathological spreading and neuronal cell death in Parkinson's disease. However, the pathophysiological effect and signaling cascade initiated by extracellular α-synuclein in cellular milieu are not well understood. Herein we have investigated the perturbations induced by low molecular weight α-synuclein and different types of α-synuclein oligomers in the neuroblastoma SH-SY5Y cells. Atomic force microscopy studies have revealed formation of nanopores and enhanced roughness in the cell surface leading to membrane disruption. The damaged membrane allows altered ionic homeostasis leading to activation of nitric oxide synthase (NOS) machinery releasing burst of nitric oxide. The elevated levels of nitric oxide induces S-nitrosylation of key proteins like Actin, DJ-1, HSP70 UCHL1, Parkin, and GAPDH that alter cytoskeletal network, protein folding machinery, ubiquitin proteasome system inducing apoptosis.
Subject(s)
Cell Membrane/drug effects , Neuroblastoma/genetics , Parkinson Disease/genetics , alpha-Synuclein/genetics , Actins/genetics , Cell Death/drug effects , Cell Line, Tumor , Cell Membrane/ultrastructure , HSP72 Heat-Shock Proteins/genetics , Humans , Microscopy, Atomic Force , Nanopores/ultrastructure , Nanostructures/chemistry , Neuroblastoma/metabolism , Neuroblastoma/ultrastructure , Neurons/drug effects , Neurons/ultrastructure , Nitric Oxide/metabolism , Parkinson Disease/metabolism , Parkinson Disease/pathology , Protein Deglycase DJ-1/genetics , Protein Folding/drug effects , Ubiquitin-Protein Ligases/genetics , alpha-Synuclein/pharmacologyABSTRACT
Neuroblastomas (NB) are one of the most common extracranial solid tumors in children, and they frequently display high heterogeneity in the disease course. With ongoing research, more information regarding the genetic etiology and molecular mechanisms underlying these contrasting phenotypes is being uncovered. The proto-oncogene MYCN is amplified in approximately 20% of NB cases and is considered a indicator of poor prognosis and an indicator of high-risk NB. The poor prognosis of high risk NB is incompletely explained by MYCN amplification. Recently, massive parallel sequencing studies reported several relatively common gene alterations, such as ATRX mutation and TERT rearrangement that are involved in telomere maintenance through telomerase activity and alternative lengthening of telomeres. Thus, these are important for understanding the etiology and molecular pathogenesis of NB, and hence, for identifying diagnostic and treatment markers. Development of telomerase inhibitors and identification of alternative lengthening of telomeres related targets will contribute to the individualized treatment for high-risk NB. In this mini-review, we will discuss the research progress of TERT-mediated and ATRX-mediated telomere maintenance and NB, especially high-risk tumors.
Subject(s)
Neuroblastoma/genetics , Telomerase/physiology , Telomere/metabolism , X-linked Nuclear Protein/physiology , Humans , Neuroblastoma/etiology , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Prognosis , Proto-Oncogene Mas , Telomere/ultrastructureABSTRACT
Eukaryotic organisms are continuously exposed to bacteriophages, which are efficient gene transfer agents in bacteria. However, bacteriophages are considered not to pass the eukaryotic cell membrane and enter nonphagocytic cells. Here we report the binding and penetration of Escherichia coli PK1A2 bacteriophage into live eukaryotic neuroblastoma cells in vitro. The phage interacts with cell surface polysialic acid, which shares structural similarity with the bacterial phage receptor. Using fluorescence and electron microscopy, we show that phages are internalized via the endolysosomal route and persist inside the human cells up to one day without affecting cell viability. Phage capsid integrity is lost in lysosomes, and the phage DNA is eventually degraded. We did not detect the entry of phage DNA into the nucleus; however, we speculate that this might occur as a rare event, and propose that this potential mechanism could explain prokaryote-eukaryote gene flow.
Subject(s)
Bacteriophages/metabolism , Endosomes/metabolism , Escherichia coli/virology , Eukaryotic Cells/metabolism , Lysosomes/metabolism , Neuroblastoma/metabolism , Sialic Acids/metabolism , Bacteriophages/ultrastructure , Capsid/metabolism , Capsid/ultrastructure , Cell Line, Tumor , DNA, Viral/metabolism , Endocytosis , Endosomes/ultrastructure , Eukaryotic Cells/ultrastructure , Gene Flow , Humans , Lysosomes/ultrastructure , Microscopy, Electron , Microscopy, Fluorescence , Neuroblastoma/ultrastructureABSTRACT
Alzheimer's disease (AD) is a complex and progressive neurological disorder, and amyloid-ß (Aß) has been recognized as the major cause of AD. Inhibiting Aß production and/or enhancing the clearance of Aß to reduce its levels are still the effective therapeutic strategies pursued in anti-AD research. In previous studies, we have reported that selenomethionine (Se-Met), a major form of selenium in animals and humans with significant antioxidant capacity, can reduce both amyloid-ß (Aß) deposition and tau hyperphosphorylation in a triple transgenic mouse model of AD. In this study, a Se-Met treatment significantly decreased the Aß levels in Neuron-2a/AßPPswe (N2asw) cells, and the anti-amyloid effect of Se-Met was attributed to its ability to inhibit Aß generation by suppressing the activity of BACE1. Furthermore, both the LC3-II/LC3-I ratio and the number of LC3-positive puncta were significantly decreased in Se-Met-treated cells, suggesting that Se-Met also promoted Aß clearance by modulating the autophagy pathway. Subsequently, Se-Met inhibited the initiation of autophagy through the AKT-mTOR-p70S6K signaling pathway and enhanced autophagic turnover by promoting autophagosome-lysosome fusion and autophagic clearance. Our results further highlight the potential therapeutic effects of Se-Met on AD.
Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Protein Precursor/genetics , Autophagy/drug effects , Gene Expression Regulation/drug effects , Selenomethionine/pharmacology , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Peptides/ultrastructure , Amyloid beta-Protein Precursor/metabolism , Amyloid beta-Protein Precursor/ultrastructure , Animals , Aspartic Acid Endopeptidases/metabolism , Autophagy/genetics , Cell Line, Tumor , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/genetics , Humans , Immunosuppressive Agents/pharmacology , Lactosylceramides/metabolism , Macrolides/pharmacology , Microscopy, Electron, Transmission , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Oncogene Protein v-akt/metabolism , Signal Transduction/drug effects , Sirolimus/pharmacology , TransfectionABSTRACT
Loss of synapse and synaptic dysfunction contribute importantly to cognitive impairment in Alzheimer's disease (AD). Mitochondrial dysfunction and oxidative stress are early pathological features in AD-affected brain. However, the effect of AD mitochondria on synaptogenesis remains to be determined. Using human trans-mitochondrial "cybrid" (cytoplasmic hybrid) neuronal cells whose mitochondria were transferred from platelets of patients with sporadic AD or age-matched non-AD subjects with relatively normal cognition, we provide the first evidence of mitochondrial dysfunction compromises synaptic development and formation of synapse in AD cybrid cells in response to chemical-induced neuronal differentiation. Compared to non-AD control cybrids, AD cybrid cells showed synaptic loss which was evidenced by a significant reduction in expression of two synaptic marker proteins: synaptophysin (presynaptic marker) and postsynaptic density protein-95, and neuronal proteins (MAP-2 and NeuN) upon neuronal differentiation. In parallel, AD-mediated synaptic deficits correlate to mitochondrial dysfunction and oxidative stress as well as activation of p38 MAP kinase. Notably, inhibition of p38 MAP kinase by pharmacological specific p38 inhibitor significantly increased synaptic density, improved mitochondrial function, and reduced oxidative stress. These results suggest that activation of p38 MAP kinase signaling pathway contributes to AD-mediated impairment in neurogenesis, possibly by inhibiting the neuronal differentiation. Our results provide new insight into the crosstalk of dysfunctional AD mitochondria to synaptic formation and maturation via activation of p38 MAP kinase. Therefore, blockade of p38 MAP kinase signal transduction could be a potential therapeutic strategy for AD by alleviating loss of synapses.
Subject(s)
Alzheimer Disease/complications , Alzheimer Disease/pathology , Mitochondria/pathology , Mitochondrial Diseases/etiology , Signal Transduction/physiology , p38 Mitogen-Activated Protein Kinases/metabolism , Adenosine Triphosphate/metabolism , Aged , Aged, 80 and over , Case-Control Studies , Cell Differentiation , Disks Large Homolog 4 Protein , Electron Transport Complex IV/metabolism , Female , Humans , Hybrid Cells , Male , Membrane Potential, Mitochondrial , Mitochondria/ultrastructure , Mitochondrial Diseases/pathology , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Oxidative Stress/physiology , Reactive Oxygen Species/metabolism , Rhodamines/metabolism , Synapses/metabolism , Synapses/pathology , Synaptophysin/metabolismABSTRACT
The purpose our study was to determine the protective effects of mitochondria division inhibitor 1 (Mdivi1) in Alzheimer's disease (AD). Mdivi1 is hypothesized to reduce excessive fragmentation of mitochondria and mitochondrial dysfunction in AD neurons. Very little is known about whether Mdivi1 can confer protective effects in AD. In the present study, we sought to determine the protective effects of Mdivi1 against amyloid-ß (Aß)- and mitochondrial fission protein, dynamin-related protein 1 (Drp1)-induced excessive fragmentation of mitochondria in AD progression. We also studied preventive (Mdivi1+Aß42) and intervention (Aß42+Mdivi1) effects against Aß42 in N2a cells. Using real-time RT-PCR and immunoblotting analysis, we measured mRNA and protein levels of mitochondrial dynamics, mitochondrial biogenesis, and synaptic genes. We also assessed mitochondrial function by measuring H2O2, lipid peroxidation, cytochrome oxidase activity, and mitochondrial ATP. MTT assays were used to assess the cell viability. Aß42 was found to impair mitochondrial dynamics, lower mitochondrial biogenesis, lower synaptic activity, and lower mitochondrial function. On the contrary, Mdivi1 enhanced mitochondrial fusion activity, lowered fission machinery, and increased biogenesis and synaptic proteins. Mitochondrial function and cell viability were elevated in Mdivi1-treated cells. Interestingly, Mdivi1 pre- and post-treated cells treated with Aß showed reduced mitochondrial dysfunction, and maintained cell viability, mitochondrial dynamics, mitochondrial biogenesis, and synaptic activity. The protective effects of Mdivi1 were stronger in N2a+Aß42 pre-treated with Mdivi1, than in N2a+Aß42 cells than Mdivi1 post-treated cells, indicating that Mdivi1 works better in prevention than treatment in AD like neurons.
Subject(s)
Amyloid beta-Peptides/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Mitochondria/drug effects , Mitochondrial Proteins/metabolism , Nerve Tissue Proteins/metabolism , Peptide Fragments/pharmacology , Quinazolinones/pharmacology , Adenosine Triphosphate/metabolism , Animals , Cell Line, Tumor , Drug Interactions , Electron Transport Complex IV/metabolism , Hydrogen Peroxide/metabolism , Lipid Peroxidation/drug effects , Mice , Mitochondrial Dynamics/drug effects , Mitochondrial Dynamics/genetics , Mitochondrial Proteins/genetics , Nerve Tissue Proteins/genetics , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , RNA, Messenger/metabolismABSTRACT
The use of nanoscale materials in the design of scaffolds for CNS tissue is increasing, due to their ability to promote cell adhesion, to mimic an extracellular matrix microenvironment and to interact with neuronal membranes. In this framework, one of the major challenges when using undifferentiated neural cells is how to control the differentiation process. Here we report the characterization of a scaffold based on the self-assembled nanotubes of a mutant of the protein peroxiredoxin (from Schistosoma mansoni or Bos taurus), which allows the growth and differentiation of a model neuronal cell line (SHSY5Y). The results obtained demonstrate that SHSY5Y cells grow without any sign of toxicity and develop a neuronal phenotype, as shown by the expression of neuronal differentiation markers, without the use of any differentiation supplement, even in the presence of serum. The prodifferentiation effect is demonstrated to be dependent on the formation of the protein nanotube, since a wild-type (WT) form of the peroxiredoxin from Schistosoma mansoni does not induce any differentiation. The protein scaffold was also able to induce the spread of glioblastoma cancer stem cells growing in neurospheres and allowing the acquisition of a neuron-like morphology, as well as of immature rat cortical neurons. This protein used here as coating agent may be suggested for the development of scaffolds for tissue regeneration or anti-tumour devices. Copyright © 2016 John Wiley & Sons, Ltd.
Subject(s)
Cell Differentiation , Neoplastic Stem Cells/pathology , Neurons/cytology , Peroxiredoxins/chemistry , Animals , Cattle , Cell Count , Cell Line, Tumor , Cell Proliferation , Humans , Neoplastic Stem Cells/ultrastructure , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Peroxiredoxins/ultrastructure , Rats, Sprague-Dawley , Schistosoma mansoni/metabolism , Spheroids, Cellular/pathologyABSTRACT
The formation of oligomers and aggregates of overexpressed or mutant α-synuclein play a role in the degeneration of dopaminergic neurons in Parkinson's disease by causing dysfunction of mitochondria, reflected in their disturbed mobility and production of ROS. The mode of action and mechanisms underlying this mitochondrial impairment is still unclear. We have induced stable expression of wild-type, A30P or A53T α-synuclein in neuronally differentiated SH-SY5Y neuroblastoma cells and studied anterograde and retrograde mitochondrial trafficking in this cell model for Parkinson's disease. In contrast to wild-type and A30P, A53T α-synuclein significantly inhibited mitochondrial trafficking, at first retrogradely and in a later stage anterogradely. Accordingly, A53T α-synuclein also caused the highest increase in ROS production in the dysmobilized mitochondria in comparison to wild-type or A30P α-synuclein. Treatment with NAP, the eight amino acid peptide identified as the active component of activity-dependent neuroprotective protein (ADNP), completely annihilated the adverse effects of A53T on mitochondrial dynamics. Our results reveal that A53T α-synuclein (oligomers or aggregates) leads to the inhibition of mitochondrial trafficking, which can be rescued by NAP, suggesting the involvement of microtubule disruption in the pathophysiology of Parkinson's disease.
Subject(s)
Mitochondria/drug effects , Mitochondria/genetics , Oligopeptides/pharmacology , alpha-Synuclein/genetics , alpha-Synuclein/metabolism , Alanine/genetics , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line, Tumor , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Humans , Kymography , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/genetics , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Mitochondria/pathology , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , RNA, Messenger/metabolism , Reactive Oxygen Species/metabolism , Threonine/genetics , Transfection , alpha-Synuclein/chemistrySubject(s)
Dopamine/pharmacology , Nerve Tissue Proteins/drug effects , Nerve Tissue Proteins/metabolism , Protein Aggregates/drug effects , Cell Line, Tumor , Humans , Microscopy, Immunoelectron , Mitochondria/drug effects , Nerve Tissue Proteins/ultrastructure , Neuroblastoma/metabolism , Neuroblastoma/pathology , Neuroblastoma/ultrastructure , Protein Transport/drug effects , Vimentin/metabolismABSTRACT
Autophagy is activated in cancer cells in response to multiple stresses and has been demonstrated to promote tumor cell survival and drug resistance in neuroblastoma (NB). This study was conducted to analyze the ultrastructural features of peripheral neuroblastic tumors (pNTs) and identify the relation of the types of NTs, the proliferation rate, and MYCN gene amplification with a number of autophagic vacuoles. Our results indicate that aggressive human NBs show a massive increase in the number of autophagic vacuoles associated with proliferation rate and that alteration of the mitochondria might be an important factor for the induction of autophagy in NTs.
Subject(s)
Autophagosomes/ultrastructure , Mitochondria/ultrastructure , Neuroblastoma/ultrastructure , Adolescent , Child , Child, Preschool , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Male , Microscopy, Electron, Transmission , N-Myc Proto-Oncogene Protein/genetics , Neuroblastoma/pathology , Vacuoles/ultrastructureABSTRACT
Different rabies virus (RABV) strains have their own biological characteristics, but little is known about their respective impact on autophagy. Therefore, we evaluated whether attenuated RABV HEP-Flury and wild-type RABV GD-SH-01 strains triggered autophagy. We found that GD-SH-01 infection significantly increased the number of autophagy-like vesicles, the accumulation of enhanced green fluorescent protein (EGFP)-LC3 fluorescence puncta and the conversion of LC3-I to LC3-II, while HEP-Flury was not able to induce this phenomenon. When evaluating autophagic flux, we found that GD-SH-01 infection triggers a complete autophagic response in the human neuroblastoma cell line (SK), while autophagosome fusion with lysosomes was inhibited in a mouse neuroblastoma cell line (NA). In these cells, GD-SH-01 led to apoptosis and mitochondrial dysfunction while triggering autophagy, and apoptosis could be decreased by enhancing autophagy. To further identify the virus constituent causing autophagy, 5 chimeric recombinant viruses carrying single genes of HEP-Flury instead of those of GD-SH-01 were rescued. While the HEP-Flury virus carrying the wild-type matrix protein (M) gene of RABV triggered LC3-I to LC3-II conversion in SK and NA cells, replacement of genes of nucleoprotein (N), phosphoprotein (P) and glycoprotein (G) produced only minor autophagy. But no one single structural protein of GD-SH-01 induced autophagy. Moreover, the AMPK signaling pathway was activated by GD-SH-01 in SK. Therefore, our data provide strong evidence that autophagy is induced by GD-SH-01 and can decrease apoptosis in vitro. Furthermore, the M gene of GD-SH-01 may cooperatively induce autophagy.